ADPT vs DTE
Adaptive Biotechnologies Corp (ADPT) versus DTE (DTE) — a side-by-side from cached financials, not a winner call.
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
DTE (DTE) common stock.
Latest reported ADPT revenue for 2024-12-31 was $179.0M. Net income was -$159.6M. Revenue was up 5.1% from 2023-12-31 to 2024-12-31. ADPT currently screens at market cap $2.69B.
DTE does not have a complete income-statement cache yet.
ADPT currently screens at market cap $2.69B. DTE currently screens at market cap $0.
Not investment advice. Open the ADPT and DTE stock pages for the full models.
Not investment advice.